CA2235415A1 - 2-alkylpyrrolidines - Google Patents

2-alkylpyrrolidines Download PDF

Info

Publication number
CA2235415A1
CA2235415A1 CA 2235415 CA2235415A CA2235415A1 CA 2235415 A1 CA2235415 A1 CA 2235415A1 CA 2235415 CA2235415 CA 2235415 CA 2235415 A CA2235415 A CA 2235415A CA 2235415 A1 CA2235415 A1 CA 2235415A1
Authority
CA
Canada
Prior art keywords
dihydroxy
compound
hydroxymethyl
formula
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2235415
Other languages
English (en)
Inventor
Karsten Lundgren
Palle Jakobsen
Marit Kristiansen
Leif Norskov-Lauritsen
Lars Naerum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/DK1996/000373 external-priority patent/WO1997009040A1/fr
Publication of CA2235415A1 publication Critical patent/CA2235415A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Il est possible, pour le traitement du diabète, d'utiliser la (2R, 3R, 4R)-3, 4-dihydroxy-2-hydroxyméthylpyrrolidine et d'autres 2-méthylpyrrolidines à substitution.
CA 2235415 1995-09-08 1996-09-06 2-alkylpyrrolidines Abandoned CA2235415A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK99295 1995-09-08
DK0992/95 1995-09-08
PCT/DK1996/000373 WO1997009040A1 (fr) 1995-09-08 1996-09-06 2-alkylpyrrolidines

Publications (1)

Publication Number Publication Date
CA2235415A1 true CA2235415A1 (fr) 1997-03-13

Family

ID=29403898

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2235415 Abandoned CA2235415A1 (fr) 1995-09-08 1996-09-06 2-alkylpyrrolidines

Country Status (1)

Country Link
CA (1) CA2235415A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9670195B2 (en) 2012-08-31 2017-06-06 Alectos Therapeutics Inc. Glycosidase inhibitors and uses thereof
US9695197B2 (en) 2012-10-31 2017-07-04 Alectos Therapeutics Inc. Glycosidase inhibitors and uses thereof
US9701693B2 (en) 2011-06-27 2017-07-11 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
US9718854B2 (en) 2011-03-31 2017-08-01 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
US9809537B2 (en) 2012-08-31 2017-11-07 Alectos Therapeutics Inc. Glycosidase inhibitors and uses thereof
US9815861B2 (en) 2010-12-23 2017-11-14 Alectos Therapeutics, Inc. Selective glycosidase inhibitors and uses thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9815861B2 (en) 2010-12-23 2017-11-14 Alectos Therapeutics, Inc. Selective glycosidase inhibitors and uses thereof
US9718854B2 (en) 2011-03-31 2017-08-01 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
US9701693B2 (en) 2011-06-27 2017-07-11 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
US9670195B2 (en) 2012-08-31 2017-06-06 Alectos Therapeutics Inc. Glycosidase inhibitors and uses thereof
US9809537B2 (en) 2012-08-31 2017-11-07 Alectos Therapeutics Inc. Glycosidase inhibitors and uses thereof
US9695197B2 (en) 2012-10-31 2017-07-04 Alectos Therapeutics Inc. Glycosidase inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
US5854272A (en) 2-alkylpyrrolidines
US5863903A (en) Use of hydroxy alkyl piperidine and pyrrolidine compounds to treat diabetes
RU2180901C2 (ru) N-замещенные 2-цианопирролидины
EP0749423B1 (fr) Piperidines et pyrrolidines
JP3681110B2 (ja) Ｎ置換されている２−シアノピロリジン
FI90415B (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-(2-aminoetoksimetyyli)-4-(2-kloorifenyyli)-3-etoksikarbonyyli-5-metoksikarbonyyli-6-metyyli-1,4-dihydropyridiinien valmistamiseksi
US5102882A (en) Pyroglutamide derivatives
CA2235415A1 (fr) 2-alkylpyrrolidines
AU779347B2 (en) Iminocyclitol inhibitors of hexoaminidase and glycosidase
EP0660822B1 (fr) Derives de benzylamino, de benzylamido et de benzylimido cycliques utilises comme agents antipsychotiques
CA1106382A (fr) Pyrrolidines substituees, procede de preparation, utilisation, et medicaments qui en contiennent
US4139620A (en) 1-Substituted-3-aminoethoxypyrrolidines and use thereof
US4218479A (en) Novel benzylalcohols and pharmaceutical compositions and use thereof
IE49122B1 (en) Derivatives of 4,5-dihydro-1h-pyrrolo-2-carboxylic acids and 1,4,5,6-tetrahydropyridine-2-carboxylic acids
KR100848490B1 (ko) 베타아미노기를 갖는 1,2,5-트리아제판 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
RO108683B1 (ro) Derivati de butinilamine si procedeu de preparare a acestora
FI106551B (fi) Menetelmä lääkeaineena käyttökelpoisen alfa-[(heterosyklyylialkoksi)fenyyli]-omega-aryylialkaani- tai alfa-((heterosyklyylioksi)fenyyli)-omega-aryylialkaaniyhdisteen valmistamiseksi
US4183933A (en) Diarylbutyl octahydropyrazinopyrimidinones and methods of medical treatment using them
KR850000844B1 (ko) 피롤리딘 유도체의 제조방법
MXPA99004281A (en) N-substituted 2-cyanopyrrolidines
AU4856293A (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents
FR2747676A1 (fr) Derives de [1-oxo-2-(sulfonylamino)ethyl] piperidine, leur preparation et leur application en therapeutique
MXPA01005817A (en) N-substituted 2-cyanopyrrolidines

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20030908